[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
November 17, 2004

Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers

JAMA. 2004;292(19):2340. doi:10.1001/jama.292.19.2340

Financial Disclosure Omitted: In the Preliminary Communication entitled “Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers” published in the July 28, 2004, issue of JAMA (2004;292:462-469), a financial disclosure was omitted. Oregon Health and Science University (OHSU), Drs Gravett, Rosenfeld, Reddy, Jacob, Roberts, and Nagalla and Mr Turner all have a significant financial interest in Proteogenix Inc, a company that may have a commercial interest in the results of this research and technology. Among the 3 investigators involved in statistical analysis of the study (Drs Gravett, Lapidus, and Hitti), the latter 2 have no potential financial interest in the results of this research. This potential conflict of interest has been reviewed and a management plan approved by the OHSU Conflict of Interest in Research Committee, and the Integrity Program Oversight Council has been implemented.

×